Human Cytokines & Growth Factors

바이오니아만의 합성유전자 생산 기술을 바탕으로 고객들이 원하는 진단 및 연구용 premade primer를 130여종 이상 합성하였으며 일반 초보 실험자 및 모든 영역에서 실험 및 연구를 수행할 수 있습니다. 

* Formats: 2 nmole of lyophilized oligo in 1.5 mL tubes

* Purification: PAGE purification

Grouped product items
상품명 수량
HUMAN T-CELL SURFACE MARKERS, CD4 (T4) / 169 bp (2 nmole) [N-1047]
₩35,000
HUMAN T-CELL SURFACE MARKERS, CD8 (LEU-2/T8) / 287 bp (2 nmole) [N-1048]
₩35,000
HUMAN ENDOTHELIAL CELL GROWTH FACTOR (ECGF) / 153 bp (2 nmole) [N-1049]
₩35,000
HUMAN GRANULOCYTE COLONY STIMULATING FACTOR (GM-CSF) / 424 bp (2 nmole) [N-1052]
₩35,000
HUMAN INTERFERON-ALPHA / 283 bp (2 nmole) [N-1053]
₩35,000
HUMAN INTERFERON-BETA / 282 bp (2 nmole) [N-1054]
₩35,000
HUMAN INTERFERON-GAMMA / 397 bp (2 nmole) [N-1055]
₩35,000
HUMAN INSULIN-LIKE GROWTH FACTOR (IGF) / 471bp (2 nmole) [N-1056]
₩35,000
HUMAN INTERLEUKIN 1-ALPHA (IL-1-alpha) / 442 bp (2 nmole) [N-1057]
₩35,000
HUMAN INTERLEUKIN 1-BETA (IL-1-beta) / 426 bp (2 nmole) [N-1058]
₩35,000
HUMAN INTERLEUKIN 2 (IL-2) / 398 bp (2 nmole) [N-1059]
₩35,000
HUMAN INTERLEUKIN 3 (IL-3) / 358 bp (2 nmole) [N-1060]
₩35,000
HUMAN INTERLEUKIN 4 (IL-4) / 375 bp (2 nmole) [N-1061]
₩35,000
HUMAN INTERLEUKIN 5 (IL-5) / 202 bp (2 nmole) [N-1062]
₩35,000
HUMAN INTERLEUKIN 6 (IL-6) / 486 bp (2 nmole) [N-1063]
₩35,000
HUMAN INTERLEUKIN 7 (IL-7) / 454 bp (2 nmole) [N-1064]
₩35,000
HUMAN INTERLEUKIN 8 (IL-8) / 300 bp (2 nmole) [N-1065]
₩35,000
HUMAN INTERLEUKIN 2 RECEPTOR / 282 bp (2 nmole) [N-1066]
₩35,000
HUMAN INTERLEUKIN 6 RECEPTOR / 203 bp (2 nmole) [N-1067]
₩35,000
TRANSFORMING GROWTH FACTOR (TGF)-ALPHA / 263 bp (2 nmole) [N-1068]
₩35,000
TRANSFORMING GROWTH FACTOR (TGF)-ALPHA / 256 bp (2 nmole) [N-1069]
₩35,000
TRANSFORMING GROWTH FACTOR (TGF)-BETA  / 161 bp (2 nmole) [N-1070]
₩35,000
TRANSFORMING GROWTH FACTOR (TGF)-BETA / 228 bp (2 nmole) [N-1071]
₩35,000
HUMAN TUMOR NECROSIS FACTOR (TNF) - ALPHA / 518 bp (2 nmole) [N-1072]
₩35,000
HUMAN TUMOR NECROSIS FACTOR (TNF) - BETA  / 179 bp (2 nmole) [N-1073]
₩35,000
Copyright © 2023 BIONEER CORPORATION. All rights reserved.